top of page

INFRAFRONTIER / IMPC Stakeholder Meeting

- Raise awareness of INFRAFRONTIER / IMPC platforms among current Personalised Medicine initiatives,
funders and policy makers
- Present use cases for the utility of animal models for identifying targets for precision therapies
- Share advances in CRISPR/Cas9 technology to model human conditions
- Strengthen interactions with Personalised Medicine initiatives and Rare Disease consortia

201906_Infra_&_EMMA.jpg

© 2014 INFRAFRONTIER.GR Project Management

InfrafrontierGR_Funding bodies_ENG_2021.
bottom of page